The EORTC tables overestimate the risk of recurrence and progression of patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin: external validation of the EORTC risk tables - Fernandez-Gomez, J; Madero, R; Solsona, E (Eur Urol, 2011)
et al.